PATIENTS taking blockbuster diabetes and weight loss drugs are waking up with vision loss, researchers warn. Some reported ...
Experts from five states have sounded the alarm about blockbuster weight loss drugs like Ozempic leaving users blind, ...
There's growing evidence to suggest that GLP-1 drugs, which include Ozempic's semaglutide, may be useful for treating alcohol ...
Court rulings against parts of Donald Trump's agenda put White House officials on the defensive. Hamas says it will not ...
Recent research suggests that a new approach could help even patients with advanced forms of fatty liver disease.
The next FDA Commissioner could solve two big problems with one powerful policy: encourage independent testing of both ...
A new review reports that nine people taking semaglutide and tirzepatide — the active ingredient in GLP-1 medications — ...
A new study published in JAMA Ophthalmology reveals that weight loss drugs like Ozempic and similar medications could cause ...
19hon MSNOpinion
The Hims brand has primed people to view both their everyday health and the natural-aging processes as problems that can be ...
Ozempic and Wegovy maker Novo Nordisk placed a print ad responding to the Super Bowl spot from competitor Hims & Hers.
PRESCRIPTIONS handed out for semaglutide - a drug used to treat diabetes and more commonly known as Ozempic - more than... Local News News Barnsley South Yorkshire ...
13h
Live Science on MSNHims & Hers Super Bowl controversy: What the ad left out about its 'alternative' weight-loss drugsThe telehealth company Hims & Hers put out a Super Bowl ad that skimped on clarifying that its compounded semaglutide medications aren't FDA-approved.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results